Saturday, October 3, 2026

EUR/CHF Is 1% Down In The Last 21 Sessions

EUR/CHF Is 1% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.88% for the last 21 sessions. At 15:07 EST on Wednesday, 19 July, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 2.004% up from its 52-week low and 4.744% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.10%, and a positive 0.22%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.24% (last week), 0.17% (last month), and 0.22% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy: 145 could now prove a solid cap – ING. According to FXStreet on Monday, 17 July, "A sustained move lower in USD/JPY will require some follow-up - i.e. either from the BoJ or US data."
  • Usd/jpy price analysis: vulnerable to retest 50% fibonacci retracement support near 137.40. According to FXStreet on Monday, 17 July, "That said, the failure to extend late Friday's corrective bounce off the multi-day low beyond the previous support line stretched from late March, now immediate resistance around 139.35, recall the USD/JPY sellers.", "It's worth noting that early May's peak of around 137.80 can act as an immediate support for the USD/JPY bears to watch whereas a sustained downside break of 137.40 will make the pair vulnerable to declining towards the 61.8% Fibonacci retracement level, surrounding 135.50."
  • Usd/jpy falls back to near 138.00 as US dollar remains uncertain ahead of retail sales. According to FXStreet on Tuesday, 18 July, "The USD/JPY pair has dropped back to near the crucial support of 138.00 in the European session. "
  • Usd/jpy ticks down to mid-138.00s, holds above two-month low touched on Friday. According to FXStreet on Monday, 17 July, "This fails to assist the USD to build on its modest bounce from the lowest level since April 2022 touched on Friday and favours the USD/JPY bears. ", "Apart from this, a mildly softer tone around the US equity futures further benefits the safe-haven JPY and contributes to capping the upside for the USD/JPY pair. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com